CRCHUM in brief

The University of Montreal Hospital Research Centre (CRCHUM) is one of the largest French-language research centres in North America. Following is an overview of our organization.

More than 1,730 people work at CRCHUM, including 439 researchers, 435 graduate students and postdoctoral fellows, 227 college or undergraduate students as well as other research interns and 852 professional, support and technical staff as well as research nurses.

Research as a pillar of a cutting-edge university hospital

CRCHUM forms an integral part of the hospital. Its director, Dr. Vincent Poitout, is also Director of Research at CHUM. This management structure promotes alignment of research activities with hospital operations.

As a university hospital affiliated with Université de Montréal, CHUM has a mission focused on care, research, teaching, health promotion and advancement of technology and treatment methods in health care. With a view to providing a continuum of care and services to the community, governance of CHUM is pooled with CHU Sainte-Justine, a mother-child hospital centre.

 

Research at CHUM

CRCHUM adheres to the policy on responsible research conduct established by the Fonds de recherche en santé du Québec (FRQS) and the Canadian Institutes of Health Research (CIHR). All research activities conducted in whole or in part at CHUM are benchmarked, listed and conducted in compliance with the highest standards of academic research.

The students we host at CRCHUM, from Université de Montréal and many other universities around the world, play an active role in the advancement of research. They conduct work in our laboratories and participate in many oral or poster presentations at conferences, seminars and thesis defences.

A lively scientific forum

As the venue for a very active scientific life, dozens of conferences and scientific activities are held each week at CRCHUM, especially seminars, thesis defences and weekly CRCHUM conferences at which internationally renowned researchers present their latest work. CRCHUM also organizes prestigious events such as the Journée scientifique du CRCHUM [scientific day], in mid-October, with the participation of a Nobel Prize recipient.

 

Université de Montréal

CRCHUM is the largest research centre affiliated with Université de Montréal. Almost all the Centre’s 439 researchers are affiliated with Université de Montréal and divide their time between research, teaching activities and, for many, clinical practice. Within Université de Montréal, they belong to the Faculty of medecine, the École de santé publique de l’Université de Montréal (ÉSPUM), the Faculty of Pharmacy, à l’École de réadaptation or the École Polytechnique Montréal. We also have links with the École de technologie supérieure (ÉTS) and Téluq, to which some researchers in the imaging and engineering section belong.

 

Research partners

The development of collaboration with other research centres in Quebec to increase the overall research capacity in health is a priority for CHUM’s Director of Research. Supported by Montréal In Vivo, the Centre hospitalier de l’Université de Montréal, the McGill University Health Centre and the Centre hospitalier universitaire Sainte-Justine have joined forces with various industrial partners to make Montreal a global centre of expertise in early clinical research. This initiative, launched in January 2015, promotes the clinical research expertise of Montreal hospitals, thereby contributing to development of the life sciences and health technology cluster in the greater Montreal area.

 

CRCHUM is associated with the research centre at CHU Sainte-Justine to foster development of an applied clinical research unit (URCA), with both centres sharing the biostatistics resources and providing high-level methodological support for patient-oriented research projects.

We also collaborate with many partners: universities, companies and investors in Canada and around the world.

From past to future

CRCHUM was formed in 1996 by joining three founding hospitals: Hôtel-Dieu, Hôpital Notre-Dame and Hôpital Saint-Luc.

In October 2013, the Centre opened a new chapter in its history when it opened a new modern research complex in the heart of downtown Montreal. The consolidation of research teams previously scattered across various sites breathed new enthusiasm into the Centre and stimulated productive multidisciplinary collaboration. The recruiting of many world-class researchers also helped position CRCHUM effectively on the world health research stage.

Since September 2015, governance of CHUM has been pooled with that of CHU Sainte-Justine, a mother-child hospital centre. This group facilitates continuity in delivery of care and services for patients of all ages, from infants to adults.

With the approaching opening of the new CHUM in 2017, patients and the public will have access to a cutting-edge university hospital complex that conducts research, delivers care and provides teaching at a single site. This new strength will create an outstanding environment to accelerate research and innovation serving patients and the public.

Main research committees and chairs

Members of the scientific committee and international advisory committee, in May 2015: Grégoire Le Gal, Janusz Kaczorowski, Paul Hébert, Daniel Kaufmann, Marcel Goldberg, Pierre Corvol, Marie-Josée Hébert, Vincent Poitout, Pierrette Gaudreau, Anne-Marie Mes-Masson, Johanne Tremblay, Marc Caron, Lise Gauvin and Alexandre Prat. Absent from the photo: Sylvie Beaulieu and Jacques de Guise.

 

Executive committee

  • Vincent Poitout, CHUM Director of Research and CRCHUM Scientific Director
  • Sylvie Beaulieu, Assistant to the CHUM Director of Research and CRCHUM Scientific Director
  • Hélène Perron, Senior Counsel, Legal Affairs Jean Déry, Adviser, Financial Resources
  • Lise Gauvin, Associate Scientific Director, Population Health Research
  • Paul Hébert, Associate Scientific Director, Clinical Research
  • Alexandre Prat, Associate Scientific Director, Academic Development
  • Pierrette Gaudreau, Associate Scientific Director, Student Affairs
  • Michel Roger, Associate Scientific Director, Basic and Translational Research
  • Carole Jabet, Associate Director, Operations, CRCHUM

Scientific committee

  • Vincent Poitout, CHUM Director of Research and CRCHUM Scientific Director Sylvie Beaulieu, Assistant to the CHUM Director of Research and CRCHUM Scientific Director
  • Lise Gauvin, Head, Risk, Prevention and Health Promotion Section and Associate Scientific Director, Population Health Research
  • Alexandre Prat, Head, Neurosciences Section and Associate Scientific Director, Academic Development
  • Johanne Tremblay, Head, Cardiometabolic Section
  • Anne-Marie Mes-Masson, Head, Cancer Section
  • Jacques de Guise, Head, Imaging and Engineering Section
  • Janusz Kaczorowski, Head, Assessment, Care Systems and Services Section
  • Daniel Kaufmann, Head, Tissue Injury, Immunity, Infection and Inflammation Section
  • Paul Hébert, Associate Scientific Director, Clinical Research
  • Pierrette Gaudreau, Associate Scientific Director, Student Affairs
  • Michel Roger, Associate Scientific Director, Basic and Translational Research Carole Jabet, Associate Director, Operations, CRCHUM

 International advisory committee

  • Marc Caron, Duke University Medical Center
  • Pierre Corvol, Collège de France Marcel Goldberg, INSERM-UVSQ Grégoire Le Gal, Ottawa Hospital Research Institute

 

Research chairs

Our researchers hold 35 research chairs. The Government of Canada and the institutions that financially support these chairs contribute directly to the excellence of our research in leading fields.

Canada Research Chairs

  • Antoine Boivin, Canada Research Chair in Patient and Public Partnership (Tier 1)
  • Jacques De Guise, Canada Research Chair in 3D Imaging and Biomedical Engineering (Tier 1)
  • Pierre Drapeau, Canada Research Chair in Neuroscience (Tier 1)
  • Pavel Hamet, Canada Research Chair in Predictive Genomics (Tier 1)
  • Jennifer L. O’Loughlin, Canada Research Chair in Early Determinants of Adult Chronic Diseases (Tier 1)
  • Alexandre Prat, Canada Research Chair in Multiple Sclerosis (Tier 1)
  • Vincent Poitout, Canada Research Chair in Diabetes and Pancreatic Beta-Cell Function (Tier 1)
  • Marc Prentki, Canada Research Chair in Diabetes and Metabolism (Tier 1)
  • Karl Fernandes, Canada Research Chair in Neural Stem Cells (Tier 2)
  • Andrés Finzi, Canada Research Chair in Retroviral Entry (Tier 2)
  • Sophie Lerouge, Canada Research Chair in Biomaterials and Endovascular Implants

CHUM Foundation and other chairs

  • Marc Bilodeau, Novartis-Canadian Liver Foundation Hepatology Research Chair, Université de Montréal
  • Jean-François Cailhier, Claude-Bertrand Neurosurgery Chair, Université de Montréal
  • Apostolos Christopoulos, Dr. Azar-Angelil ORL Oncology Research Chair
  • José Côté, Research Chair in Innovative Nursing Practices, Université de Montréal
  • Jacques De Guise, Marie-Lou and Yves Cotrel Research Chair in Orthopedics, Université de Montréal Véronique Dubé, Marguerite-d’Youville Research Chair on Humanistic Interventions in Nursing
  • Pasquale Ferraro, Alfonso Minicozzi and Family Research Chair in Thoracic Surgery and Lung Transplantation
  • Nathalie Grandvaux, Research Chair in Signalling of Viral Infections and Oncogenesis, Université de Montréal
  • Marie-Josée Hébert, Shire Chair in Nephrology and Renal Transplantation and Regeneration, Université de Montréal
  • Paul Hébert, Héma-Québec – Bayer Foundation Chair in Transfusion Medicine, Université de Montréal
  • Janusz Kaczorowski, Dr. Sadok Besrour Chair in Family Medicine
  • Janusz Kaczorowski, GlaxoSmithKline Research Chair in Optimal Management of Chronic Disease Y
  • an Kestens, Applied Public Health Chair in Urban Interventions and Population Health
  • Réal Lapointe, Roger-Des-Groseillers Chair in Hepatobiliary and Pancreatic Oncological Surgery, Université de Montréal
  • Moishe Liberman, Marcel and Rolande Gosselin Chair in Thoracic Surgical Oncology, Université de Montréal
  • Jean-Pierre Pelletier and Johanne Martel-Pelletier, Université de Montréal Chair in Osteoarthritis Louise Potvin, Chair in Community Approaches and Health Inequality (CACIS) Stéphane Potvin, Eli Lilly Canada Chair in Schizophrenia
  • André Robidoux, Scotia Bank Chair in Breast Cancer Diagnosis and Treatment, Université de Montréal
  • Fred Saad, Université de Montréal Chair in Prostate Cancer Research
  • Jean-Luc Sénécal, Université de Montréal Scleroderma Research Chair
  • Jack Siemiatycki, Guzzo Environment-Cancer Research Chair of the Cancer Research Society
  • John Stagg, Jean-Guy Sabourin Family Pharmaceutical Chair in Women’s Health ICM
  • Cécile Tremblay, Pfizer Chair in Clinical and Translational Research on HIV, Université de Montréal